• This is the non-PPA version of the course. If you would prefer to take the PPA version of the course please click here


    • Professor Patrick Vermersch, Vice Dean, University of Lille, CHRU de Lille, Lille International Research Inflammation Centre (LIRIC), Lille, France
    • Professor Antonio Uccelli, Professor of Neurology, Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Università di Genova, Italy
    • Professor Tobias Derfuss, Professor of Medicine and Senior Physician, Departments of Neurology and Biomedicine at University Clinic, Basel, Switzerland
    • Professor Gavin Giovannoni, Chair of Neurology, Blizard Institute, Queen Mary University of London, London, United Kingdom

    Course overview

    The programme covers newer treatment strategies in MS, how they work, and how to implement them into clinical practice. This six module e-learning course includes content from the UEMS/EACCME-accredited meeting “Integrating Innovations in the Treatment of Multiple Sclerosis into Clinical Practice” to enhance the interactive online learning modules.

    Target audience

    This educational activity is intended for any healthcare professionals involved in the treatment of patients with multiple sclerosis

    Learning objectives

    Upon completing of the programme, participants should be able to:

    • Understand the evolution of the multiple sclerosis treatment landscape over the last 25 years, in particular how our evolving understanding of the disease has guided the development of new therapies
    • Describe the current and new strategies for treating multiple sclerosis, including the use of new agents
    • Identify the risks and benefits of these treatment strategies when implementing them in daily practice


    This programme has been partly supported by an independent educational grant from Merck KGaA, Darmastadt, Germany


    An application has been made to the UEMS EACCME for CME accreditation of this course